Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
QuintilesIMS
Federal Trade Commission
Deloitte
Mallinckrodt
Covington
Harvard Business School
Chinese Patent Office
Chubb

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020486

« Back to Dashboard

NDA 020486 describes VANCERIL DOUBLE STRENGTH, which is a drug marketed by Schering and is included in one NDA. Additional details are available on the VANCERIL DOUBLE STRENGTH profile page.

The generic ingredient in VANCERIL DOUBLE STRENGTH is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
Summary for 020486
Tradename:VANCERIL DOUBLE STRENGTH
Applicant:Schering
Ingredient:beclomethasone dipropionate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.084MG/INH
Approval Date:Dec 24, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Harvard Business School
Cerilliant
Fuji
Dow
Johnson and Johnson
Fish and Richardson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot